Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception

Am J Reprod Immunol. 2010 Feb;63(2):110-9. doi: 10.1111/j.1600-0897.2009.00768.x. Epub 2009 Dec 15.

Abstract

Problem: Female genital tract secretions inhibit herpes simplex virus (HSV) infection, however, the intra- and inter-subject variability, contribution of specific mediators, and impact of reproductive hormones have not been defined.

Method: of study Cervicovaginal lavage (CVL) (n = 89) obtained from nine cyclers and seven women on hormonal contraception (HC), who completed between three and eight weekly visits, were examined for anti-herpes simplex virus activity and concentrations of mediators.

Results: The CVL inhibited HSV infection by a mean value of approximately 57% during the follicular or luteal phase, but only by 36% in hormonal contraceptive users. Human neutrophil peptides 1-3 (HNP1-3) (P = 0.03), IL-8 (P = 0.003), lactoferrin (P = 0.005), lysozyme (P = 0.003), IgA (P = 0.002), and IgG (P = 0.02) correlated with antiviral activity. Intra-subject and inter-subject variability was observed, suggesting that factors other than hormones contribute to innate defense.

Conclusion: Endogenous antimicrobial activity may provide a biomarker of healthy mucosal immunity and may be reduced in the setting of HC. However, larger prospective studies are needed.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Cervix Uteri / immunology
  • Contraceptives, Oral, Hormonal / pharmacology
  • Female
  • Genitalia, Female / immunology*
  • Genitalia, Female / virology*
  • Herpes Genitalis / immunology*
  • Herpes Genitalis / prevention & control*
  • Herpesvirus 2, Human / immunology*
  • Humans
  • Immunity, Mucosal* / drug effects
  • Pilot Projects
  • Prospective Studies
  • Solubility
  • Vagina / immunology
  • Young Adult

Substances

  • Contraceptives, Oral, Hormonal